Filip, S.; Kubeček, O.; Špaček, J.; Lánská, M.; Bláha, M.
Therapeutic Apheresis, Circulating PLD, and Mucocutaneous Toxicity: Our Clinical Experience through Four Years. Pharmaceutics 2020, 12, 940.
https://doi.org/10.3390/pharmaceutics12100940
AMA Style
Filip S, Kubeček O, Špaček J, Lánská M, Bláha M.
Therapeutic Apheresis, Circulating PLD, and Mucocutaneous Toxicity: Our Clinical Experience through Four Years. Pharmaceutics. 2020; 12(10):940.
https://doi.org/10.3390/pharmaceutics12100940
Chicago/Turabian Style
Filip, Stanislav, Ondřej Kubeček, Jiřà Špaček, Miriam Lánská, and Milan Bláha.
2020. "Therapeutic Apheresis, Circulating PLD, and Mucocutaneous Toxicity: Our Clinical Experience through Four Years" Pharmaceutics 12, no. 10: 940.
https://doi.org/10.3390/pharmaceutics12100940
APA Style
Filip, S., Kubeček, O., Špaček, J., Lánská, M., & Bláha, M.
(2020). Therapeutic Apheresis, Circulating PLD, and Mucocutaneous Toxicity: Our Clinical Experience through Four Years. Pharmaceutics, 12(10), 940.
https://doi.org/10.3390/pharmaceutics12100940